UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 131

Sortiert nach

Personal Protective Equipment: Protecting Health Care Providers in an Ebola Outbreak

Clinical therapeutics, 2015-11, Vol.37 (11), p.2402-2410

2015

Volltextzugriff (PDF)

Confronting Ebola as a Sexually Transmitted Infection

Clinical infectious diseases, 2016-05, Vol.62 (10), p.1272-1276

2016

Volltextzugriff (PDF)

COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2

PloS one, 2021-12, Vol.16 (12), p.e0260879-e0260879

2021

Volltextzugriff (PDF)

Antiviral Activity, Pharmacokinetics, and Safety of BMS-488043, a Novel Oral Small-Molecule HIV-1 Attachment Inhibitor, in HIV-1-Infected Subjects

Antimicrobial Agents and Chemotherapy, 2011-02, Vol.55 (2), p.722-728

2011

Volltextzugriff (PDF)

Simplification to abacavir/lamivudine + atazanavir maintains viral suppression and improves bone and renal biomarkers in ASSURE, a randomized, open label, non-inferiority trial

PloS one, 2014-05, Vol.9 (5), p.e96187

2014

Volltextzugriff (PDF)

Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO)

Antiviral therapy, 2014-01, Vol.19 (2), p.191-200

2014

Volltextzugriff (PDF)

Ezetimibe Alone Reduces Low-Density Lipoprotein Cholesterol in HIV-Infected Patients Receiving Combination Antiretroviral Therapy

Clinical infectious diseases, 2008-10, Vol.47 (8), p.1105-1108

2008

Volltextzugriff (PDF)

Randomized Study of the Safety and Efficacy of Fish Oil (Omega-3 Fatty Acid) Supplementation with Dietary and Exercise Counseling for the Treatment of Antiretroviral Therapy—Associated Hypertriglyceridemia

Clinical infectious diseases, 2005-11, Vol.41 (10), p.1498-1504

2005

Volltextzugriff (PDF)

Does HAART efficacy translate to effectiveness? Evidence for a trial effect

PloS one, 2011-07, Vol.6 (7), p.e21824-e21824

2011

Volltextzugriff (PDF)

Timing and Duration of Incarceration and High-Risk Sexual Partnerships Among African Americans in North Carolina

Annals of epidemiology, 2008-05, Vol.18 (5), p.403-410

2008

Volltextzugriff (PDF)

Raltegravir Pharmacokinetics in Treatment-Naive Patients Is Not Influenced by Race: Results from the Raltegravir Early Therapy in African-Americans Living with HIV (REAL) Study

Antimicrobial Agents and Chemotherapy, 2013-02, Vol.57 (2), p.784-788

2013

Volltextzugriff (PDF)

Hospitalization Rates and Outcomes Among Persons Living With Human Immunodeficiency Virus in the Southeastern United States, 1996-2016

Clinical infectious diseases, 2020-10, Vol.71 (7), p.1616-1623

2020

Volltextzugriff (PDF)

The Impact of Discharge Against Medical Advice on Readmission After Opioid Use Disorder-Associated Infective Endocarditis: a National Cohort Study

Journal of general internal medicine : JGIM, 2023-05, Vol.38 (7), p.1615-1622

2023

Volltextzugriff (PDF)

Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial

The lancet HIV, 2019-06, Vol.6 (6), p.e355-e363

2019

Volltextzugriff (PDF)

Increased Persistence of Initial Treatment for HIV Infection With Modern Antiretroviral Therapy

Journal of acquired immune deficiency syndromes (1999), 2017-10, Vol.76 (2), p.111

2017

Volltextzugriff (PDF)

The clinical impact of continuing to prescribe antiretroviral therapy in patients with advanced AIDS who manifest no virologic or immunologic benefit

PloS one, 2013-11, Vol.8 (11), p.e78676-e78676

2013

Volltextzugriff (PDF)

COVID-19 hospitalization risk after outpatient nirmatrelvir/ritonavir use, January to August 2022, North Carolina

Journal of antimicrobial chemotherapy, 2024-04, Vol.79 (4), p.859-867

2024

Volltextzugriff (PDF)

Comparative Pharmacokinetics of Tixagevimab/Cilgavimab (AZD7442) Administered Intravenously Versus Intramuscularly in Symptomatic SARS‐CoV‐2 Infection

Clinical pharmacology and therapeutics, 2022-12, Vol.112 (6), p.1207-1213

2022

Volltextzugriff (PDF)

A randomized, double-blind comparison of single-tablet regimen elvitegravir/cobicistat/emtricitabine/tenofovir DF versus single-tablet regimen efavirenz/emtricitabine/tenofovir DF for initial treatment of HIV-1 infection: analysis of week 144 results

Journal of acquired immune deficiency syndromes (1999), 2014-03, Vol.65 (3), p.e118

2014

Volltextzugriff (PDF)

Long-term Complications of Ebola Virus Disease: Prevalence and Predictors of Major Symptoms and the Role of Inflammation

Clinical infectious diseases, 2020-10, Vol.71 (7), p.1749-1755

2020

Volltextzugriff (PDF)

Sexuality, Sexual Practices, and HIV Risk Among Incarcerated African-American Women in North Carolina

Women's health issues, 2013-11, Vol.23 (6), p.e357-e364

2013

Volltextzugriff (PDF)

Anti-Ebola Virus Antibody Levels in Convalescent Plasma and Viral Load After Plasma Infusion in Patients With Ebola Virus Disease

The Journal of infectious diseases, 2018-07, Vol.218 (4), p.555-562

2018

Volltextzugriff (PDF)

The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy

AIDS research and human retroviruses, 2020-04, Vol.36 (4), p.324

2020

Volltextzugriff (PDF)

Participant Perspectives in an HIV Cure-Related Trial Conducted Exclusively in Women in the United States: Results from AIDS Clinical Trials Group 5366

AIDS research and human retroviruses, 2020-04, Vol.36 (4), p.268

2020

Volltextzugriff (PDF)

1 – 25 von 131

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(128)
Mit Volltextzugriff
(87)

Publikationsform

Artikel
(131)

Sprache

Englisch
(131)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Humans
(130)
Science & Technology
(124)
Male
(122)
Life Sciences & Biomedicine
(119)
Adult
(99)
Infectious Diseases
(81)
Middle Aged
(71)
Human Immunodeficiency Virus
(68)
Hiv
(67)
Hiv Infections - Drug Therapy
(62)
Biological And Medical Sciences
(44)
Medical Sciences
(43)
Immunology
(40)
Viral Diseases
(35)
Aids/hiv
(33)
Human Viral Diseases
(33)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(32)
Antiretroviral Drugs
(31)
Adolescent
(30)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study

Personal Protective Equipment: Protecting Health Care Providers in an Ebola Outbreak

Confronting Ebola as a Sexually Transmitted Infection

COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2

Antiviral Activity, Pharmacokinetics, and Safety of BMS-488043, a Novel Oral Small-Molecule HIV-1 Attachment Inhibitor, in HIV-1-Infected Subjects

Simplification to abacavir/lamivudine + atazanavir maintains viral suppression and improves bone and renal biomarkers in ASSURE, a randomized, open label, non-inferiority trial

Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO)

Ezetimibe Alone Reduces Low-Density Lipoprotein Cholesterol in HIV-Infected Patients Receiving Combination Antiretroviral Therapy

Randomized Study of the Safety and Efficacy of Fish Oil (Omega-3 Fatty Acid) Supplementation with Dietary and Exercise Counseling for the Treatment of Antiretroviral Therapy—Associated Hypertriglyceridemia

Does HAART efficacy translate to effectiveness? Evidence for a trial effect

Timing and Duration of Incarceration and High-Risk Sexual Partnerships Among African Americans in North Carolina

Raltegravir Pharmacokinetics in Treatment-Naive Patients Is Not Influenced by Race: Results from the Raltegravir Early Therapy in African-Americans Living with HIV (REAL) Study

Hospitalization Rates and Outcomes Among Persons Living With Human Immunodeficiency Virus in the Southeastern United States, 1996-2016

The Impact of Discharge Against Medical Advice on Readmission After Opioid Use Disorder-Associated Infective Endocarditis: a National Cohort Study

Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial

Increased Persistence of Initial Treatment for HIV Infection With Modern Antiretroviral Therapy

The clinical impact of continuing to prescribe antiretroviral therapy in patients with advanced AIDS who manifest no virologic or immunologic benefit

COVID-19 hospitalization risk after outpatient nirmatrelvir/ritonavir use, January to August 2022, North Carolina

Comparative Pharmacokinetics of Tixagevimab/Cilgavimab (AZD7442) Administered Intravenously Versus Intramuscularly in Symptomatic SARS‐CoV‐2 Infection

A randomized, double-blind comparison of single-tablet regimen elvitegravir/cobicistat/emtricitabine/tenofovir DF versus single-tablet regimen efavirenz/emtricitabine/tenofovir DF for initial treatment of HIV-1 infection: analysis of week 144 results

Long-term Complications of Ebola Virus Disease: Prevalence and Predictors of Major Symptoms and the Role of Inflammation

Sexuality, Sexual Practices, and HIV Risk Among Incarcerated African-American Women in North Carolina

Anti-Ebola Virus Antibody Levels in Convalescent Plasma and Viral Load After Plasma Infusion in Patients With Ebola Virus Disease

The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy

Participant Perspectives in an HIV Cure-Related Trial Conducted Exclusively in Women in the United States: Results from AIDS Clinical Trials Group 5366

Aktive Filter

Suchergebnisse filtern